Abstract Two new compounds, 8Ј-phospho derivatives of amicoumacins A and B, were isolated from the culture broth of a strain of Bacillus pumilus together with amicoumacins A and B. Their structures were elucidated on the basis of spectroscopic methods and alkaline phosphatase treatments. Comparison of the antibacterial activities against methicillin-resistant Staphylococcus aureus (MRSA) of these compounds suggested that C-8Ј hydroxyl and C-12Ј amide group of amicoumacin A played a critical role for anti-MRSA activity.
Dihydroisocoumarin derivatives are mostly implicated as having physiological roles such as plant-microbe interactions [1ϳ3] . The isolation of amicoumacins A (1) and B (2) [4ϳ6] and closely related AI-77s [7, 8] from Bacillus pumilus evoked interest in medicinal research because of their characteristic biological activities including antibacterial, anti-inflammatory, antiulcer, gastroprotective, and anti-Helicobacter pylori activities [1ϳ3, 7, 9, 10] . Their unique basic structures ( Fig. 1 ) of the dihydroisocoumarin with a hydroxy amino acid side chain have attention from synthetic chemists, and there are a number of total syntheses and synthetic approaches, represented by Cappiello et al. [11] and references cited therein. The structurally related antibiotics with different hydroxy amino acid side chains, baciphelacin [12] , Y-05460M-A [13] , PM-94128 [14] , xenocoumacins [15] , and Sg17-1-4 [16] , all with significant activities, represent a growing number of antibiotics in this class.
In our screening program for new antibiotics against methicillin-resistant Staphylococcus aureus (MRSA), 1 was isolated from the culture broth of strain MU313B which was newly isolated from a soil sample. The strain, which was identified as Bacillus pumilus by 16S rDNA analysis, also produced 2 [4ϳ6] and two new amicoumacin derivatives (3 and 4). In this paper, we describe the structure determination of two new amicoumacin A derivatives and compare their parent compounds, 1 and 2. 
Results and Discussion
After the initial identification of 1 as an anti-MRSA active substance, other peaks with similar UV spectra were detected in the culture broth, suggesting that these were derivatives of 1. Fig. 2 shows a typical time-course for production of compound 1 to 4 in the fermentation broth. Production of 1 began 24 hours after inoculation and increased until about 36 hours. The titre of 1 was then gradually decreased to 72 hours. 2 to 4 were only detected in significant amounts after 36 hours. These compounds were, thus isolated from 36-hour cultures.
The culture supernatant was treated with SepPak VacC 18 , and the eluate with 70% aq MeOH was subjected to preparative HPLC to give pure 1 (Rt: 29ϳ35 minutes, 6.0 mg). 2 to 4 were purified by the same procedure for 1. The physico-chemical properties and NMR spectral data of 4 and 3 were very similar to those of amicoumacin A and B [6] , respectively (Tables 1 and 2 ). The molecular formula of 4 was revealed to be C 20 To confirm the structures of 4 and 3, these compounds were treated with alkaline phosphatase at pH 8.8. As a result, compounds 4 or 3 were converted to 1 or 2, Production of amicoumacins was estimated from the peak intensity of HPLC analyses with detection by wavelength at 315 nm. The injection volume of culture broth was 100 ml. -; 1, -᭹; 2, -᭡; 3, -ϫ; 4.
respectively (data not shown). These results showed that 4 or 3 were 8Ј-phospho derivatives of amicoumacin A or B, respectively. Treatment of 4 with alkaline phosphatase also afforded 2 and 3 together with 1. 4 may be converted to 3 under these conditions as 1 is similarly converted to 2.
To clarify the structure-activity relationship of hydroxy amino acid moiety of amicoumacins, antibacterial activity of 1 to 4 against Staphylococcus aureus ATCC 43300 was measured. The MICs of these compounds were shown in Table 3 . The activity of 1 was almost equivalent to that of vancomycin. On the other hand, 2 to 4 showed no activity at the concentrations tested. These results suggested that C-8Ј hydroxyl and C-12Ј amide group of 1 play a critical role for anti-MRSA activity.
The amicoumacins are a family of structurally diverse products that possess a broad range of pharmacological properties such as antibacterial, anti-inflammatory, antiulcer, gastroprotective, and anti-Helicobacter pyroli activities. Their varying activities may be related to the hydroxy amino acid moiety, because these compounds have the common dihydroisocoumarin structure. This is the first report of the isolation of C-8Ј modified amicoumacin derivatives and their evaluation for antibacterial activity, though some studies of structure-activity relationships have been reported in these compounds. In this study, we showed 754 Table 2 1 H-, 13 C-and 31 P-NMR chemical shifts of 3 and 4 3 4 that C-8Ј hydroxyl and C-12Ј amide group of 1 play a critical role for anti-MRSA activity. The importance of the C-12Ј amide group for anti-MRSA activity agrees with the structural requirements for other biological activities [6] . This study has shown that the antibacterial activity of amicoumacin A is a dramatically decreased by phosphorylation at the C-8Ј hydroxyl group. Time course experiments showed that 4 was produced as concentrations of 1 declined. Phosphorylative inactivation of antibiotics is known [17ϳ20], and considered as one of the resistance mechanisms to antibiotics. Two alternative hydroxyl groups, C-8Ј and C-9Ј, are available for Ophosphorylation in the amicoumacin structures. Our analysis revealed the exclusive phosphorylation of the C-8Ј hydroxyl group. Phosphorylation of amicoumacins is, thus an interesting finding possibly in relation to self-resistance and export of amicoumacins. Interestingly, amicoumacin production is distributed not only in B. pumilus but also in the other Bacillus species [21] , and its biological significance is of great interest in the Bacillus genus.
Experimental

General
HPLC analysis was performed with a TOSOH 8020 system fitted with a diode array detector. Preparative HPLC was performed using a Waters 600E system fitted with diode array detector.
1 H-NMR (400 MHz), 13 C-NMR (100 MHz) and 31 P-NMR (162 MHz) spectra were recorded on a JEOL JNM-ECX400 spectrometer. Liquid chromatography timeof-flight mass spectrometry (LC TOF-MS) data were obtained under electron spray ionization (ESI) on a Waters LCT Premier TM . Optical rotation was measured on a digital polarimeter P-1020 (JASCO).
Microorganism and Taxonomy
The producing strain MU313B was isolated from a soil sample collected in Tsukuba City, Ibaraki prefecture, Japan. A stock culture of the strain was maintained on yeast extract -malt extract agar medium consisting of yeast extract 0.4%, malt extract 1.0%, glucose 0.4%, and agar 1.8% (pH 7.3) at 30°C. A segment of the 16S rDNA was amplified by colony-PCR using the primer sets of 9F (5Ј-GAGTTTGATCCTGGCTCAG-3Ј) and 1541R (5Ј-AAGGAGGTGATCCAGCC-3Ј) [22] in a final volume of 100 ml for 30 cycles of amplification using a step program (30 seconds at 95°C, 30 seconds at 55°C, and 1 minute at 72°C). Gel-purified PCR products were subjected to DNA sequencing service (the Bio Matrix Inc., Japan). The producing organism, the strain MU313B, was identified as Bacillus pumilus based on the complete identity of the 16S rDNA sequence with that (accession no. DQ870735) in the GenBank database.
Culture Conditions
A maintenance culture of the strain MU313B was inoculated into 500-ml Erlenmeyer flask containing 50 ml of culture medium composed of glucose 2.0%, NaNO 3 0.2%, K 2 HPO 4 0.1%, KCl 0.05%, MgSO 4 · 7H 2 O 0.05%, FeSO 4 · 7H 2 O 0.001%, peptone 0.5%, yeast extract 0.1%, and soybean meal 2.0% (pH 7.0, before sterilization), and cultured at 30°C for 36 hours on a rotary shaker (200 rpm).
HPLC Analysis 1 to 4 in the fermentation broth and conversion experiments were analyzed under the following conditions: column; SunFire (4.6 i.d.ϫ150 mm, Waters), column temperature 40°C, gradient elution, solvent A (MeOH) and solvent B (0.2% ammonium acetate in water), gradient rate; 0ϳ10 minutes (50% A), 10ϳ13 minutes (50 →100% A, linear), 13ϳ17 minutes (100% A), 17ϳ20 minutes (100 →50% A, linear), flow rate; 1.0 ml/minute, detection; wavelength between at 230ϳ400 nm using photo diode array.
Isolation of 1 to 4
For isolation of 1 to 4, the culture broth (4.9 liter) was centrifuged at 1,600 g for 20 minutes to obtain the supernatant which was treated with SepPak VacC 18 cartridge (Waters). After washing with 50% aq MeOH, the active substance was eluted from the cartridge with 70% aq MeOH. These material were lyophilized and, were redissolved in 50% aq MeOH containing 0.1% ammonium acetate to subject a reversed-phase HPLC under following condition: column; SunFire (19 i.d.ϫ150 mm, Waters), column temperature 40°C, gradient elution, solvent A (MeOH) and solvent B (0.2% ammonium acetate in water), gradient rate; 0ϳ35 minutes (45% A), 35ϳ38 minutes (45→100% A, linear), 38ϳ47 minutes (100% A), flow rate; 7.0 ml/minute, detection; wavelength between at 210ϳ400 nm using photo diode array. These fractions were then desalted using same column with 50ϳ60% aq MeOH containing 0.5% AcOH as a mobile phase at the flow rate of 7.0 ml/minute.
Dephosphorylation of 3 and 4
A solution (200 ml) of bovine alkaline phosphatase (0.5 u, sigma P7640) and 0.3 mM of 3 or 4 in 50 mM Tris-HCl (pH 8.8) was incubated at 37°C for 5 hours. The reaction was stopped by adding to same volume of MeOH and then centrifuged to obtain a sample solution. The solution was subjected to a reversed-phase HPLC.
